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Background: Cryopreserved ovarian cortical tissue acts as a source of primordial follicles (PF) which can either be
auto-transplanted or cultured in vitro to obtain mature oocytes. This offers a good opportunity to attain biological
parenthood to individuals with gonadal insufficiency including cancer survivors. However, role of various intra- and
extra-ovarian factors during PF growth initiation still remain poorly understood. Ovarian biology has assumed a
different dimension due to emerging data on presence of pluripotent very small embryonic-like stem cells (VSELs)
and ovarian germ stem cells (OGSCs) in ovary surface epithelium (OSE) and the concept of postnatal oogenesis. The
present study was undertaken to decipher effect of follicle stimulating hormone (FSH) and basic fibroblast growth
factor (bFGF) on the growth initiation of PF during organ culture with a focus on ovarian stem cells.
Methods: Serum-free cultures of marmoset (n=3) and human (young and peri-menopausal) ovarian cortical tissue pieces
were established. Cortical tissue pieces stimulated with FSH (0.5 IU/ml) or bFGF (100 ng/ml) were collected on Day 3 for
histological and molecular studies. Gene transcripts specific for pluripotency (Oct-4A, Nanog), early germ cells (Oct-4, c-Kit,
Vasa) and to reflect PF growth initiation (oocyte-specific Gdf-9 and Lhx8, and granulosa cells specific Amh) were studied
by q-RTPCR.
Results: A prominent proliferation of OSE (which harbors stem cells) and transition of PF to primary follicles was observed
after FSH and bFGF treatment. Ovarian stem cells were found to be released on the culture inserts and retained the
potential to spontaneously differentiate into oocyte-like structures in extended cultures. q-RTPCR analysis revealed an
increased expression of gene transcripts specific for VSELs, OGSCs and early germ cells suggestive of follicular transition.
Conclusion: The present study shows that both FSH and bFGF stimulate stem cells present in OSE and also lead to PF
growth initiation. Thus besides being a source of PF, cryopreserved ovarian cortical tissue could also be a source of stem
cells which retain the ability to spontaneously differentiate into oocyte-like structures in vitro. Results provide a paradigm
shift in the basic understanding of FSH action and also offer a new perspective to the field of oncofertility research.
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Culture of ovarian cortical tissue is carried out to allow the
transition of resting phase primordial follicles (PF) to pri-
mary and secondary follicular stage. This is an interesting
in vitro system to investigate the basic mechanisms in-
volved in the activation and development of PF. This ap-
proach has also been implicated as a possible option to* Correspondence: bhartiyad@nirrh.res.in
1Stem Cell Biology Department, National Institute for Research in
Reproductive Health (NIRRH), JM Street, Parel, Mumbai 400 012, India
Full list of author information is available at the end of the article
© 2013 Parte et al.; licensee BioMed Central Lt
Commons Attribution License (http://creativec
reproduction in any medium, provided the orachieve biological parenthood in women cancer survivors
and cryopreservation of ovarian cortical tissue is currently
performed prior to cancer treatment for preservation of
their fertility [1-4]. Currently, the practiced strategy in-
volves auto-transplantation of cryopreserved ovarian tissue
post cancer treatment. But, this may pose a high risk of re-
introducing cancer in spite of remission from disease.
Hence in the context of fertility preservation, in vitro mat-
uration of PF from cryopreserved tissue is an excellent op-
tion for such females and also for those who wish to delay
pregnancy for career or other reasons.d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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follicle development of all stages, as the concentration and
optimal timing of nutrient/growth factor requirements is
stage-specific and not yet deciphered completely. Hence, a
two-step procedure for follicular maturation has been pro-
posed. The first stage involves serum-free culture of cor-
tical tissue for 3-6 days, wherein the PF transitions to
primary and secondary stage. This would be followed by
in vitro maturation of cumulus-oocyte-complexes [2,3].
Recently, 3D culture of follicles for maturation of the
oocytes has also shown promising results [5].
Till date, many intra- and extra-ovarian factors re-
quired for PF activation and follicle development in
organ cultures have been studied. Role of follicle stimu-
lating hormone (FSH), an extra-ovarian factor, during PF
transition remains controversial. It has emerged as a sur-
vival factor [6] however the mechanisms underlying FSH
action are not clear. PF growth is considered to be inde-
pendent of FSH action as they (PF) lack FSH receptors
[7,8]. Silva et al [9] reported that PF get activated spon-
taneously in caprine ovarian tissue culture and do not
require FSH or EGF. Although both FSH and EGF stim-
ulated an increase in oocyte and follicle size in inter-
mediate and primary follicles in 5 days culture, no effect
on proliferation or viability of follicles was observed in
response to the treatment. Recently it has been sug-
gested that FSH might act indirectly on the PF through
paracrine factors secreted by large follicles or stromal
cells [10]. This argument however remains unclear since
FSH acts as a survival factor despite absence of large fol-
licles in the cortical tissue pieces. Thus, more careful
studies are necessary to understand the role of FSH as
a survival factor.
Another important factor attributed to PF transition is
basic fibroblast growth factor (bFGF). It is expressed in
the ooplasm of primordial and primary follicles and also
in the ovarian surface epithelium (OSE), smooth muscle
cells surrounding blood vessels and corpus luteum [11].
Basic FGF when combined with FSH promoted PF sur-
vival and development in goats [12]. bFGF is also specu-
lated to have a role in follicle recruitment and growth by
stimulating granulosa cell proliferation [11]. Quennell
et al [13] demonstrated the presence of bFGF transcripts
in PF as well as decrease in its levels as the follicles grew
in size. Garor et al [14] demonstrated the role of bFGF
in human PF transition to primary follicles. Tang et al
[15] reported that bFGF improved the effect of FSH on
PF development and survival during long term culture
of bovine ovarian tissue.
It was interesting to observe that FSH receptors and
bFGF are expressed in the ovary surface epithelium [11,16]
which also lodges ovarian stem cells [17-20]. Further bFGF
is known to be a crucial component of culture medium re-
quired to maintain the pluripotency of human embryonicstem cells [21-24]. This emerging understanding motivated
us to undertake the present study to investigate the
in vitro effect of FSH and bFGF on PF growth with a focus
on ovarian stem cells in the ovarian cortical tissues of
marmoset and human ovaries. Day 3 (D3) was chosen as
the time point for various analyses in the present study,
since available studies suggest that spontaneous activation
of PF occurs within 2-3 days in vitro [25-28]. Histological
and q-RTPCR analysis have been carried out for various
stem cell, oocyte and granulosa cell specific markers
(please refer to the Additional file 1: Table S1) to study the
effect of FSH and bFGF on ovarian stem cells and PF
growth in vitro.
Material and methods
Procurement of ovarian tissue
The study for the use of marmoset ovaries was approved
by the Institute Animal Ethics Committee of National
Institute for Research in Reproductive Health (NIRRH).
Use of human ovarian tissue for research was approved
by the Human Ethics Committee of NIRRH and King
Edward Memorial (KEM) Hospital. Ovarian tissue was
collected from marmosets (n=3; normal cycling young
adults, 3 to 4 years of age) and women (n=2; one young
ovarian sample from a postmortem case of a 13 years
old girl collected 6-7 hrs after death and one adult ovary
from a peri-menopausal woman undergoing total ab-
dominal hysterectomy) for the study. The young ovarian
sample was collected at the time of autopsy from the
Surgical Pathology unit and the peri-menopausal ovarian
sample was procured from the Obstetrics and Gynecology
unit, KEM Hospital. All the culture studies and further
analysis were carried out at NIRRH.
Ovarian cortical tissue culture
Ovarian tissue was transported in 0.9% normal saline-
containing antibiotics (penicillin 100 U/ml, streptomycin
100 μg/ml; Invitrogen, Carlsbad, CA, USA) at ambient
temperature to the laboratory. It was gently rinsed sev-
eral times in calcium and magnesium-free Dulbecco’s
phosphate-buffered saline (DPBS; Invitrogen) containing
antibiotics. Ovarian cortical tissue (6-8 pieces of 1 mm3
size) were placed on 0.4 μm Millicell-CM inserts
(Millipore, Bedford, MA, USA) fitted within six-well plates
(NUNC, USA) and cultured at the interface between air
and 1.1 ml of culture media, similar to that described pre-
viously [14]. The basal culture medium comprised of
alpha-MEM (Invitrogen) containing 0.47 M ribonucleo-
tides, 2 mM/L sodium pyruvate (Sigma-Aldrich, USA),
2 mM/L L-glutamine (Sigma-Aldrich), 1% insulin, trans-
ferrin, and selenium (Sigma-Aldrich), 0.05% Penicillin-
Streptomycin (Invitrogen) and 2% human serum albumin
(Sigma Aldrich). Ovarian tissues were treated with 0.5 IU/
ml human urinary FSH [Utrofol, Kuanart Pharmaceuticals,
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Inc, MN, USA]. Thus three different group of cultures
were established including (A) untreated control (basal
medium) (B) FSH treated [basal media supplemented with
FSH], and (C) bFGF treated [basal media supplemented
with bFGF]. Cultures were maintained in 5% CO2 at 37°C
and were monitored regularly under an inverted micro-
scope with Hoffman optics (Eclipse TE2000-S; Nikon,
Japan). The cortical tissue pieces were collected from the
cell culture inserts after three days and processed for hist-
ology and RNA extraction. The peri-menopausal ovarian
tissue was treated only with FSH due to sample limitations.
Details of various studies undertaken are shown in Table 1.
In addition, cells observed to be released from the cortical
tissue on to the surface of the cell culture inserts, were fur-
ther cultured and regularly monitored up to three weeks.
Histology of ovarian cortical tissue
Cortical tissue pieces collected were fixed in 10% neutral
buffered formalin for 12 hours at 4°C and subsequently
dehydrated in a series of alcohol grades and processed
for paraffin embedding using standard protocols. 5 μm
thin sections were cut, stained with H & E and images
of representative areas were captured using Nikon 90i
Microscope (Nikon, Tokyo, Japan).
RNA extraction and q-RTPCR studies
Levels of transcripts for pluripotent stem cells (Oct-4A,
Nanog), early germ cells/oocyte specific (Oct-4, c-Kit,


















√: experiment done; ND: experiment not done.(oocyte-specific Gdf-9 and Lhx8, and granulosa cell specific
Amh) were analyzed by q-RTPCR. Both total Oct-4
(comprising various isoforms) and Oct-4A (transcript spe-
cific for pluripotency) were studied to arrive at meaningful
data showing the presence of VSELs and differentiated
OGSCs respectively, as reported earlier [19].
Total RNA was extracted from the ovarian tissue pieces
collected on D3 using standard TRIZOL (Invitrogen)
method. RNA extraction method and cDNA preparation
procedures were similar to those described earlier [19].
Real-time PCR analysis was performed using 2.5 μL of
cDNA and 10 pmol of gene specific primers (Table 2). The
comparative threshold cycle (Ct) values were calculated
using CFX 96 Real-Time PCR system (Bio-Rad Laborato-
ries, CA, USA) using SYBR Green chemistry (Bio-Rad).
Amplification conditions comprised of an initial de-
naturation at 95°C for 3 min, followed by 45 cycles of
denaturation at 94°C for 30s, annealing for 30s at re-
spective temperature followed by elongation at 72°C for
50 sec. The melt curve analysis was performed at the
end of 45 cycles to determine the homogeneity of the
amplified products. The Ct values generated by CFX
manager software (Bio-Rad) were normalized with respect
to housekeeping gene 18S rRNA for all samples, and the
Delta-Delta Ct values for each gene transcript were com-
puted manually by subtracting delta Ct value of treated
sample with that of its respective untreated control. Data
obtained by q-RTPCR analysis using three adult marmo-
sets, one each of young and peri-menopausal human
ovarian samples are represented individually. All reactionsrian cortical tissue
ls of ovary samples used in the study







FSH bFGF FSH bFGF
√ √ √ ND
√ √ √ ND
√ √ √ ND
√ √ √ ND
√ √ √ ND
√ √ ND ND
√ √ ND ND
√ √ ND ND
Table 2 List of primer details and PCR cycling conditions used in the study
Gene Primer sequence Annealing temperature (°C) Amplicon size (bp)
Pluripotent markers (Human)
Oct-4A F: AGCCCTCATTTCACCAGGCC 57°C 448
R: TGGGACTCCTCCGGGTTTTG
Nanog F: TGCAAATGTCTTCTGCTGAGAT 57°C 285
R: GTTCAGGATGTTGGAGAGTTC
Early germ cell markers (Human)
Oct-4 F: GAAGGTATTCAGCCAAACGAC 55°C 315
R: GTTACAGAACCACACTCGGA
Oct-4 (marmoset) F: CCCCTGGTGCTGTGAAGCTGG 64°C 124
R: CCCCAGGGTGAGCCCCACAT
c-Kit F: CCTGGGATTTTCTCTGCGTT 60°C 376
R: ATTGGTCACTTCTGGGTCTG
Vasa F: GAC TGC GGC TTT TCT CCT ACC 55°C 418
R: TTT GGC GCT GTT CCT TTG AT
PF transition markers (Human)
Amh F: CACCTGGAGGAAGTGACCTG 60°C 202
R: CCACCGCTAACACCAGGTAG
Amh (marmoset) F: ACCTGGAGGAAGTGACATGG 64°C 190
R: ACCAGGTAGTGGGTGTCTCG
Gdf-9 F: CTCCTGGAGACCAGGTAACAGGAAT 65°C 291
R: TGCACACACATTTGACAGCAGAGG
Lhx8 F: CAAGCACAATTTGCTCAGGA 62°C 230
R: GGCACGTAGGCAGAATAAGC
Housekeeping gene (Human)
18S F: GGAGAGGGAGCCTGAGAAAC 60°C 171
R: CCTCCAATGGATCCTCGTTA
Amh (granulosa cells), Gdf-9 and Lhx8 (oocyte specific).
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peated thrice to determine the reproducibility of the results.
Results
Microscopic examination of ovarian cortical tissue
Cortical tissue pieces cultured on the membrane of cell
culture inserts appeared dark under the inverted micro-
scope (Figure 1A-C, F-H). However, few cells including
RBCs interspersed with VSELs & OGSCs (ranging in size
from 1-7 μm) and larger epithelial cells (15-20 μm) were
observed to be released onto the culture insert membrane
surface in both marmoset (Figure 1D) and human ovarian
tissue culture (Figure 1E). OSE layer at high magnification
was visible in human cortical tissue (Figure 1 F-H).
Regular monitoring of the released cells on the cell
culture inserts showed that the epithelial cells attached
to membrane surface and formed a monolayer. The stem
cells (VSELs and OGSCs) appeared to grow in size and
differentiate spontaneously into oocyte-like structures
(Figure 1I-K) by the end of three weeks similar to ovarysurface epithelium cultures reported earlier by various
groups [18,19,29].
Histological analysis of ovarian cortical tissue
Marmoset
Sections of the ovarian cortical tissue prior to culture
demonstrated intact OSE layer and several intact PF
(Figure 2). The OSE comprised of discontinuous and
small cuboidal cells. Large numbers of PF were observed
with a single layer of flattened granulosa cells (GC) sur-
rounding the central oocyte. No signs of pycnotic nuclei,
eosinophilia of ooplasm or clumping of the chromatin ma-
terial were detected in the PF (Figure 2A), suggesting that
the follicles were healthy.
The untreated control ovarian tissue on D3 in culture
exhibited disorganization of the cortical stroma. The
OSE layer appeared intact and continuous comprising of
short cuboidal cells whereas the PF showed no initiation
of growth (Figure 2B, C). The tissue sections of FSH
treated cortical tissue revealed relatively better preserved
Figure 1 Microscopic observation of ovarian cortical tissue: A large number of cells were observed on the membrane of cell culture inserts
in (A) marmoset, (B) young and (C) peri-menopausal human ovary. (D & E) Stem cells (asterix) which exist in the OSE layer were visualized at
higher magnification on the inserts along with RBCs (arrow) and epithelial cells. (F-H) In peri-menopausal ovarian tissue, these cells appeared to
be released from the ovarian surface in the presence of (F) FSH and (G) bFGF compared to the (H) untreated control. The released cells were
further cultured for three weeks and spontaneously differentiated into oocyte-like structures in (I) marmoset (J) young and (K) peri-menopausal
human ovary samples. Scale bar in A-C, F-H = 20 μm and D, E, I-K = 10 μm.
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pertrophy and comprised of tall and columnar epithelial
cells (Figure 2D). The granulosa cells in few follicles
appeared cuboidal rather than flat, suggesting PF growth.
Primary follicles with few intact PF were also observedFigure 2 Histology of marmoset ovarian cortical tissue: (A) OSE and PF
staining prior to culture. (B & C) Three days culture in untreated control sh
cortex (D & E) Ovarian tissue sections after FSH treatment showed OSE pro
stage as evident by change in shape of the surrounding granulosa cells fro
layers after growth (E). (F & G) Ovarian tissue sections after bFGF treatment
and secondary stage. Inset in F shows a darkly stained stem cell amongst O(Figure 2E). The tissue harvested at D3 post treatment
with bFGF appeared intact, similar to the FSH treated
group. OSE appeared multi-layered with small spherical
cells having high nucleocytoplasmic ratio and Hematoxylin
stained dark nuclei were visible in some fields (inset,were visualized in cortical tissue sections after Haematoxylin & Eosin
owed minimal OSE, few PF with pycnotic nuclei and disorganized
liferation and PF growth and transition to primary and secondary
m flat and single layered in untreated control (A) to cuboidal and 2-3
showed OSE proliferation and PF growth and transition to primary
SE cells. Scale bar = 20 μm.
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and secondary follicles were observed in the cortex
(Figure 2G).
Human
In case of young human ovarian tissue, the OSE was
discontinuous (data not shown) and relatively few in-
tact PF were observed in the cortex before initiation
of culture (Figure 3A). Some degree of transition of PF
with flat GC to primary stage with cuboidal GC was
observed in both FSH and bFGF treated groups, com-
pared to untreated control sample which comprised
majorly of PF (Figure 3B-D). The peri-menopausal
ovarian sample had a well-defined OSE but was devoid of
any follicles (Figure 3E). The OSE was unaffected after
three days culture in the untreated group (Figure 3F),
however it was multilayered and prominent after FSH
treatment (Figure 3G).
Expression of pluripotent stem cells, germ cells and PF
transition specific transcripts
Levels of transcripts for pluripotent stem cells (Oct-4A,
Nanog), early germ cells/oocyte specific (Oct-4, c-Kit,
Vasa) and to reflect PF transition into primary follicles
(oocyte-specific Gdf-9 and Lhx8 and granulosa cell spe-
cific Amh) were analyzed. The transition specific
markers were not studied in peri-menopausal tissue as
this sample lacked PF. There was considerable biological
variation in q-RTPCR results between samples but the
basic trend remained similar while comparing data
obtained in marmosets with that from human samples.
Results were represented as fold change values over un-
treated control taken as 1 after normalizing with house-
keeping gene (18S rRNA gene) and graphs were plotted
on a logarithmic scale.Figure 3 Histology of human ovarian cortical tissue. (A-D) Young ovar
(A) OSE was not visualized but PF were seen in the cortex prior to culture
Healthy primary follicles were observed in the cortex after three days cultu
OSE and stroma devoid of follicles in peri-menopausal ovarian tissue (F) Lo
days culture without any treatment (G) FSH treatment resulted in proliferatPluripotent stem cell markers
Both Oct-4A and Nanog transcripts showed increased
expression in marmoset and human cortical tissues
treated with FSH and bFGF (Figure 4). Typically human
sample showed an increase in Oct-4A transcripts in re-
sponse to FSH treatment whereas Nanog mRNA was
expressed to higher extent in bFGF treated group. FSH
treatment in marmoset ovarian tissue showed higher ex-
pression of Nanog whereas bFGF treated group showed
higher expression of Oct-4A transcripts. Typically young
human ovary samples exhibited high fold change values
for Nanog in both treated groups, whereas expression
of both transcripts was comparable in the adult (peri-
menopausal) sample.Early germ cell markers
A prominent and uniform up-regulation of germ cell
specific markers was noticed after FSH and bFGF treat-
ment in both marmoset and human samples compared
to untreated control. Of all the three markers studied, Vasa
showed highest fold change followed by c-Kit and Oct-4
in all the samples except young human sample treated
with bFGF. Expression of early germ cell markers was
most pronounced in young human sample. Although ex-
pression of c-Kit increased minimally with FSH treatment,
the bFGF group did not exhibit any fluctuation in fold
change value in marmoset sample. There was a consistent
up-regulation of c-Kit in human samples in both treatment
groups (Figure 4).Markers to study PF growth and transition to primary follicle
An increase in the expression of transition specific markers
was noted in all the groups suggesting PF growth ini-
tiation (Figure 4).ian tissue sections and (E- G) Peri-menopausal ovarian tissue sections
(B) Untreated group revealed disorganized stroma with distorted PF.
re with (C) FSH and (D) bFGF treatment. (E) Prominent single layer of
ss of epithelial cells and disorganized stroma were evident after three
ion and multi-layered appearance of OSE. Scale bar = 20 μm.
Figure 4 Effect of bFGF and FSH on expression of pluripotent, germ cell and PF transition specific markers by q-RTPCR: Expression of
pluripotent markers (Oct-4A and Nanog), early germ cell markers (Oct-4, c-Kit and Vasa) and PF growth initiation markers (oocyte specific Gdf-9,
Lhx8 and granulosa cells specific Amh) were clearly up-regulated in response to bFGF and FSH treatment compared to untreated control (except
Lhx-8 in marmoset after bFGF treatment). Values depicted are mean fold change in logarithmic scale obtained with respect to untreated controls
taken as 1 and 18S rRNA as house-keeping gene. Marmoset data represents results obtained from three animals, whereas human data is
representative of one young and one peri-menopausal ovary. ND:Experiment not done.
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The present study was undertaken to evaluate the effect
of FSH and bFGF on PF transition from resting to grow-
ing stage during marmoset and human ovarian cortical
tissue culture. Results revealed that in addition to the
transition of resting PF to growing phase (as indicated
by histological studies and increased expression of Gdf-9,
Lhx-8 and Amh transcripts by q-RTPCR), proliferation
of the OSE cells along with a release of stem cells onto
the cell culture inserts was observed in response to FSH
and bFGF. Also an increased expression of pluripotent
stem cell (Oct-4A, Nanog) and germ cell (Oct-4, c-Kit,
Vasa) specific markers was observed. A higher fold in-
crease of stem cell markers was observed by q-RTPCR
in the young human ovarian sample. Stem cells released
on the inserts retained the ability to spontaneously dif-
ferentiate into oocyte-like structures as reported earlier
by our group [19]. Results of the present study demon-
strate a direct role of FSH and bFGF on ovarian stem
cells and PF growth initiation. These observations chal-
lenge the existing paradigm which suggests that FSHexerts indirect action on the germ cells via its receptors
on granulosa cells and that initial follicular growth is
gonadotropin independent [30].
Both FSH and bFGF induced increase in proliferation of
OSE and also increased expression of pluripotent markers
Oct-4A and Nanog in all the groups including the peri-
menopausal human ovarian sample devoid of PF. Expres-
sion of pluripotent stem cell markers Oct-4A and Nanog
indirectly suggested the presence of pluripotent very small
embryonic-like stem cells (VSELs) in the OSE as reported
earlier by our group [19]. VSELs appear to increase in num-
ber after FSH or bFGF treatment. The increased expression
of Oct-4A and Nanog as revealed by q-RTPCR, however
may not reflect the true increase as large numbers of these
stem cells were shed on to the membrane of cell culture in-
sert, which were not processed for RNA extraction. Pres-
ence of stem cells in peri-menopausal ovary and their
increase after FSH treatment suggests that stem cells persist
and retain the ability to proliferate but menopause sets in
due to a compromised microenvironment (somatic niche)
which does not allow the stem cells to differentiate and
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[19,20,31] and also others [32].
A similar increase in pluripotent stem cells and PF as-
sembly in FSH analog treated mice has been reported by
us [31]. It was intriguing to observe that FSH exerts ac-
tion on the cortical tissue pieces comprising mainly of
PF which are reported to be devoid of FSH receptors [8].
FSH action leading to follicular maturation is mediated
via the granulosa cells of growing follicles which express
FSH receptors [30,33]. Further studies are required to
investigate the mechanism of FSH action on the ovarian
stem cells.
Two distinct stem cell populations exist in the OSE in-
cluding VSELs and their immediate descendants OGSCs
[19]. We have earlier proposed that in the mammalian
ovary, VSELs give rise to OGSCs just like the VSELs in
the testis give rise to Adark spermatogonial stem cells
[19,20]. These immediate descendant ‘progenitors’ have
cytoplasmic OCT-4B and divide rapidly whereas the
VSELs express nuclear OCT-4A and are relatively quies-
cent. Presence of these two populations of stem cells in
the gonads is in agreement with the recent reports dem-
onstrating two distinct stem cell populations in various
body tissues [34,35].
Available literature suggests that transition of PF into
primary to secondary follicles occurs within 8-20 days of
ovarian cortical tissue culture. We were indeed surprised
to observe varying degree of damage to the PF in the
histological sections. In view of this, survival of PF in ex-
tended cultures is rather intriguing. The poor morphol-
ogy could be due to compromised culture condition or
a fixation artifact in the present study. But we used cul-
ture conditions based on recent studies [14] and stand-
ard fixation protocols. This forced us to contemplate
whether it is the pre-existing PF in cortical tissue or new
follicles assembled from the ovarian stem cells which
further grow into primary to secondary stage in the
long-term (conducive environment of ) culture condi-
tions. We have earlier proposed that PF assemble in the
OSE wherein the VSELs differentiate into oocytes and
the epithelial cells undergo epithelial-mesenchymal tran-
sition to give rise to granulosa cells [19,20,31]. Garor et al
[14] also observed an increased number of PF in bFGF
treated ovarian cortical tissue culture (reported 301 folli-
cles in the presence of 50 ng/ml of bFGF compared to 151
follicles in untreated control; presumably from similar
number of cortical tissue pieces). However, it remains un-
clear whether the increase in number of follicles reported
by them was due to better survival or de novo PF assembly
from the stem cells in response to the treatment. More
studies need to be undertaken in this direction. In the
present study, an increased expression of transition associ-
ated markers for oocyte (Gdf-9 and Lhx-8) and granulosa
cells (Amh) were observed after the treatment, suggestiveof PF transition into primary follicles, in agreement with
published literature [36-38].
Stimulation of pluripotent stem and early germ cell
specific markers by bFGF was not surprising since bFGF
receptors are reported to be present in the OSE [11]. Ex-
pression of above and PF transition specific markers
were increased by several folds more after bFGF treat-
ment compared to FSH, especially in young human
ovarian tissue. Our results are in agreement with Garor
et al. [14] who have also reported enhanced PF develop-
ment in response to bFGF treatment during ovarian
cortical tissue culture. It is likely that FSH and bFGF
interact under normal circumstances in the ovary, to fa-
cilitate neo-oogenesis followed by PF assembly in mam-
malian ovary. FSH may exert its action via bFGF, as
direct bFGF treatment leads to the enhanced effect. Es-
pecially the young human ovarian tissue responded more
prominently to treatment with bFGF (>8 to 9 folds
higher expression in bFGF compared to >2-3 folds in
case of FSH group). However, more samples need to be
studied before arriving at a final conclusion. Synergistic
effect of FSH and bFGF in driving stem and germ cell
development also requires further investigation.
The young human ovarian sample procured from aut-
opsy, used in the present study, showed presence of few
PF whereas the stem cells survived post death and
exhibited increased stimulation by FSH and bFGF treat-
ment. A better survival of stem cells compared to the PF
could be because stem cells survive hypoxic conditions
better in agreement with a recent study wherein viable
stem cells were isolated seventeen days post death and
they retained the ability to differentiate into skeletal
muscles [39].
To conclude, culture of ovarian cortical tissue pieces is
an excellent tool to study ovarian stem cell biology along
with PF transition. Both FSH and bFGF stimulate the
ovarian stem cells and probably aid in the assembly of
stem cells as PF during extended cultures. It will be of
great interest to study whether long-term culture of peri-
menopausal ovarian tissue can result in PF assembly from
the stem cells in response to FSH and bFGF treatment.
Results of the present study have translational potential
for both oncotherapy and infertility.
Additional file
Additional file 1: Table S1. Details of markers used for characterization
of pluripotent stem cells, germ cells and primordial follicle transition.
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